The Journal of Rheumatology

Reduced Chemokine and Matrix Metalloproteinase Expression in Patients with RA Achieving Remission

A. Katrib, M.D. Smith, M.J. Ahern, et al .........10

Synergistic Effect on the Attenuation of Collagen Induced Arthritis in TNFRI and IL-6 Double Knockout Mice

N. Yamaguchi, S. Ohshima, M. Umeshita-Sasai, et al .........22

Pretreatment Cytokine Profiles of Peripheral Blood Mononuclear Cells and Serum from Patients with RA in Different ACR Response Groups to MTX

M. Seitz, M. Zwicker, P.M. Villiger .........28

Increase in Cardiovascular and Cerebrovascular Disease Prevalence in RA

F. Wolfe, B. Freundlich, W.L. Straus .........36

Pilot Clinical Trial of IV Doxycycline Versus Placebo for RA

S. Pillemer, P. Gulko, S. Ligier, et al .........41

Patient Compliance in RA, PMR, and Gout

E. de Klerk, D. van der Heijde, R. Landewé, H. van der Tempel, J. Urquhart, S. van der Linden .........44

Cyclic-AMP Agonists Inhibit Antiphospholipid/ß₂-Glycoprotein I Induced Synthesis of Human Platelet Thromboxane A₂in Vitro

R. Opara, D.L. Robbins, V.A. Ziboh .........55

NO Synthase 2 Promoter Polymorphisms and SLE in African-Americans

J.C. Oates, M.C. Levesque, M.R. Hobbs, et al .........60

Correlation of Serum Collagen I Carboxyterminal Telopeptide Concentrations with Cutaneous and Pulmonary Involvement in SSc

Y. Allanore, D. Borderie, H. Lemaréchal, B. Cherruau, O.G. Ekindjian, A. Kahan .........68

Comprehensive Study of Autonomic Function in a Population with Primary SS. No Evidence of Autonomic Involvement

R.K. Niemelä, M. Hakala, H.V. Huikuri, K.E.J. Airaksinen .........74

Baseline Features and Initial Treatment as Predictors of Remission and Relapse in Wegener's Granulomatosis

W. Koldingsnes, J.C. Nossent .........80

Structural Characterization of a Case-Implicated Contaminant, "Peak X," in Commercial Preparations of 5-Hydroxytryptophan

K. Klarskov, K.L. Johnson, L.M. Benson, et al .........89

The Influence of the HLA-DRB1 RA Shared Epitope on the Clinical Characteristics and Radiological Outcome of PsA

E. Korendowych, J. Dixey, B. Cox, S. Jones, N. McHugh .........96

Lack of Association of AS with the Most Common NOD2 Susceptibility Alleles to Crohn's Disease

I. Ferreirós-Vidal, J. Amarelo, F. Barros, A. Carracedo, J.J. Gómez-Reino, A. Gonzalez .........102

Sporadic Enteric ReA and Undifferentiated SpA: Evidence for Involvement of Salmonella typhimurium

R. Sinha, A. Aggarwal, K. Prasad, R. Misra .........105

Knee OA Compromises Early Mobility Function: The Women's Health and Aging Study II

S.M. Ling, L.P. Fried, E.S. Garrett, M-U. Fan, T. Rantanen, J.M. Bathon .........114

Association of Heterozygous Hemochromatosis C282Y Gene Mutation with Hand OA

J.M. Ross, R.M. Kowalchuk, J. Shaulinsky, L. Ross, D. Ryan, P.D. Phatak .........121

Consistent Low Prevalence of Arthritis in Quebec: Findings from a Provincial Variation Study in Canada Based on Several Canadian Population Health Surveys

P.P. Wang, E.M. Badley .........126

A Cost Effectiveness Analysis of Calcium and Vitamin D Supplementation, Etidronate, and Alendronate in the Prevention of Vertebral Fractures in Women Treated with Glucocorticoids

L.M. Buckley, B.E. Hillner .........132

Illness Behavior and Psychosocial Factors in Diffuse Upper Limb Pain Disorder: A Case-Control Study

P.D. White, M. Henderson, R.M. Pearson, A.R. Coldrick, A.G. White, B.L. Kidd .........139

Detection of IL-1ß, IL-6, and TNF-a in Skin of Patients with FM

S. Salemi, J. Rethage, U. Wollina, et al .........146

FM, Rheumatologists, and the Medical Literature: A Shaky Alliance

D. Goldenberg, N. Smith .........151

A Study of Standard Care in FM Syndrome: A Favorable Outcome

M-A. Fitzcharles, D. Da Costa, R. Pöyhiä .........154

Health Related Quality of Life Among Adults Reporting Arthritis: Analysis of Data from the Behavioral Risk Factor Surveillance System, US, 1996-99

F. Mili, C.G. Helmick, M.M. Zack, D.G. Moriarty .........160

The Stanford Health Assessment Questionnaire: A Review of Its History, Issues, Progress, and Documentation

B. Bruce, J.F. Fries .........167

Pediatric Rheumatology

Bone Status Evaluation with Calcaneal Ultrasound in Children with Chronic Rheumatic Diseases. A One Year Followup Study

F. Falcini, G. Bindi, G. Simonini, et al .........179

Clinical and Diagnostic Value of Genetic Testing in 216 Israeli Children with FMF

S. Padeh, Y. Shinar, E. Pras, et al .........185

Case Reports

Temporal Artery Bruits in a Patient with GCA

S.T. Persellin, M.D. Cohen, W.W. Ginsburg, K.T. Calamia, J.C. Waldorf, A. Khoor .........191

Linear Scleroderma en Coup de Sabre and Brain Calcification: Is There a Pathogenic Relationship?

D.E. Flores-Alvarado, J.A. Esquivel-Valerio, M. Garza-Elizondo, L.R. Espinoza .........193

Ankle and Hindfoot Arthropathy in Hereditary
Hemochromatosis

H. Schmid, C. Struppler, G.S. Braun, W. Kellner, H. Kellner .........196

Images in Rheumatology

A Medial Soft Tissue Mass of the Knee

R. De Stefano, E. Selvi, R. Cosentino, S. Manganelli, E. Frati, R. Marcolongo .........200

Correspondence

Not For Sale, Not Even For Rent: Just Say No. Thoughts About the ACR Adopting a Code of Ethics M.H. Ellman .........202

Reply R.S. Panush .........202

Do Gastroprotective Drugs Prevent NSAID Toxicity? D.H. Solomon, J. Avorn .........203

Reply F. Wolfe, T.A. Burke, D. Pettitt .........203

Treatment Resistant AS with Peripheral Joint Involvement—A Case for Infliximab? P. Hrycaj, J.K. Lacki .........204

Reply W.P. Maksymowych, A.S. Russell .........206

Clinical and Immunological Factors Associated with Low Lacrimal and Salivary Flow Rate in Patients with Primary SS J. Pijpe, W.W.I. Kalk, A. Vissink .........206

Reply H-J. Haga .........207

Letters

Intrathecal Corticosteroids for SLE with CNS Involvement M. Funauchi, M. Ohno, Y. Nozaki, M. Sugiyama, K. Kinoshita, A. Kanamaru .........207

Lupus-like Syndrome and Vasculitis Induced by Valpromide F. Bonnet, P. Morlat, S. de Witte, C. Combe, J. Beylot .........208

Correction

Expanding Role of Biologic Agents in Rheumatoid Arthritis. J.R. Kalden .........209

Notices